Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation

Journal of Oral Pathology and Medicine

Volumn 35, Issue 1, 2006, Pages 46-50

  Ebrahimi, Majid ^a   Wahlin, Ylva Britt ^a   Coates, Philip J ^b   Sjöström, Björn ^c   Nylander, Karin ^a  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Graft vs. host disease; Oral lichen planus; p63; Squamous cell carcinoma

Indexed keywords

CD8 ANTIBODY; ISOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DO7; MONOCLONAL ANTIBODY KI 67; MONOCLONAL ANTIBODY KN ALPHA; MONOCLONAL ANTIBODY KN DELTA; MONOCLONAL ANTIBODY KN TA; PROTEIN P53; PROTEIN P63; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CHEEK MUCOSA; CONTROLLED STUDY; FEMALE; GENE; GENE DISRUPTION; GENE MUTATION; GRAFT VERSUS HOST REACTION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MOUTH DISEASE; MOUTH INFLAMMATION; MOUTH LICHEN PLANUS; MOUTH MUCOSA; ORAL BIOPSY; P63 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DNA-BINDING PROTEINS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GRAFT VS HOST DISEASE; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH MUCOSA; MOUTH NEOPLASMS; MUTATION; PHOSPHOPROTEINS; PRECANCEROUS CONDITIONS; STOMATITIS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 33645213828     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2005.00376.x     Document Type: Article

References (28)

1. Axéll T Rundqvist L Oral lichen planus - a demographic study Community Dent Oral Epidemiol 1987 15 52 6
2. de Moura Castro Jacques C Cardozo Pereira AL Cabral MG Cardoso AS Ramos-e-Silva M Oral lichen planus: Part I. Epidemiology, clinics, etiology, immunopathogeny, and diagnosis Skinmed 2003 2 342 7
3. Sugerman PB Savage NW Oral lichen planus: causes, diagnosis and management Aust Dent J 2002 47 290 7
4. Epstein JB Wan LS Gorsky M Zhang L Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003 96 32 7
5. Dissemond J Oral lichen planus: an overview J Dermatolog Treat 2004 15 136 40
6. Pindborg JJ Reichart PA Smith CJ van der Waal I Histological typing of cancer and precancer of the oral mucosa In World Health Organization international histological classification of tumours 2nd edn Berlin, Germany Springer 1997 29 30
7. Rodstrom PO Jontell M Mattsson U Holmberg E Cancer and oral lichen planus in a Swedish population Oral Oncol 2004 40 131 8
8. Hasseus B Jontell M Brune M Johansson P Dahlgren UI Langerhans cells and T cells in oral GVHD and OLP Scand J Immunol 2001 54 516 24
9. Szeto CH Shek TW Lie AK Au WY Yuen AP Kwong YL Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Am J Hematol 2004 77 200 2
10. Lishner M Patterson B Kandel R et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients Cancer 1990 65 473 6
11. Millen FJ Rainey MG Hows JM Burton PA Irvine GH Swirsky D Oral squamous cell carcinoma after allogeneic bone marrow transplantation for Fanconi anaemia Br J Haematol 1997 99 410 4
12. Otsubo H Yokoe H Miya T et al. Gingival squamous cell carcinoma in a patient with chronic graft-versus-host disease Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997 84 171 4
13. Balkwill F Montovani A Inflammation and cancer: back to Virchow Lancet 2001 357 539 45
14. Mignogna MD Fedele S Lo Russo L Lo Muzio L Bucci E Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence Oral Oncol 2004 40 120 30
15. Weitzman SA Gordon LI Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis Blood 1990 76 655 63
16. Hofseth LJ Saito S Hussain SP et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation Proc Natl Acad Sci U S A 2003 100 143 8
17. Yang A Kagdah M Wang Y et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 1998 2 305 16
18. Ghioni P Bolognese F Dujif PHG van Bokhoven H Mantovani R Guerrini L Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains Mol Cell Biol 2002 22 8659 68
19. Hall PA Campbell SJ O'Neill M et al. The expression of the p53 homologue, p63α and ΔNp63α in normal and neoplastic cells Carcinogenesis 2000 21 153 60
20. Nylander K Coates PJ Hall PA Characterisation of the expression pattern of p63α and ΔNp63α in benign and malignant oral epithelial lesions Int J Cancer 2000 87 368 72
21. Nylander K Vojtesek B Nenutil R et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells J Pathol 2002 198 417 27
22. Thurfjell N Coates PJ Uusitalo T et al. Complex p63 mRNA isoform expression patterns in squamous cell carcinoma of the head and neck Int J Oncol 2004 25 27 35
23. Bockmühl U Schlüns K Küchler I Petersen S Petersen I Genetic imbalances with impact on survival in head and neck patients Am J Pathol 2000 157 369 75
24. Sniezek JC Matheny KE Westfall MD Pietenpol JA Dominant negative p63 isoform expression in head and neck squamous cell carcinoma Laryngoscope 2004 114 2063 72
25. Hall PA McKee PH Menage HD Dover R Lane DP High levels of p53 protein in UV-irradiated normal human skin Oncogene 1993 8 203 7
26. Liefer KM Koster MI Wang XJ Yang A McKeon F Roop DR Down-regulation of p63 is required for epidermal UV-B-induced apoptosis Cancer Res 2000 60 4016 20
27. Hildesheim J Belova GI Tyner SD Zhou X Vardanian L Fornace AJ Jr. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation Oncogene 2004 23 1829 37
28. Hibi K Trink B Patturajan M et al. AIS is an oncogene amplified in squamous cell carcinoma Proc Natl Acad Sci U S A 2000 97 5462 7